Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 110

1.

Estimating the incidence of atrial fibrillation in single-chamber implantable cardioverter defibrillator patients.

Zweibel S, Cronin EM, Schloss EJ, Auricchio A, Kurita T, Sterns LD, Gerritse B, Lexcen DR, Cheng A.

Pacing Clin Electrophysiol. 2019 Feb;42(2):132-138. doi: 10.1111/pace.13555. Epub 2018 Dec 13.

PMID:
30478983
2.

Pacemaker lead surveillance and failure: Is there a signal in the noise?

Sterns LD.

Heart Rhythm. 2019 Apr;16(4):579-580. doi: 10.1016/j.hrthm.2018.11.011. Epub 2018 Nov 9. No abstract available.

PMID:
30419353
3.

Outcomes of paroxysmal atrial fibrillation ablation studies are affected more by study design and patient mix than ablation technique.

Ferreira-Martins J, Howard J, Al-Khayatt B, Shalhoub J, Sohaib A, Shun-Shin MJ, Novak PG, Leather R, Sterns LD, Lane C, Lim PB, Kanagaratnam P, Peters NS, Francis DP, Sikkel MB.

J Cardiovasc Electrophysiol. 2018 Nov;29(11):1471-1479. doi: 10.1111/jce.13745. Epub 2018 Oct 30.

PMID:
30230101
4.

Comparison of ICD shock rates in Japanese and non-Japanese patients in the PainFree SST study.

Kurita T, Ando K, Ueda M, Shizuta S, Okamura H, Matsumoto N, Gerritse B, Fagan DH, Schloss EJ, Meijer A, Auricchio A, Sterns LD, Okumura K; PainFree SST investigators.

Pacing Clin Electrophysiol. 2018 Sep;41(9):1185-1191. doi: 10.1111/pace.13427. Epub 2018 Aug 13.

PMID:
29928759
5.

Canadian Registry of Implantable Electronic Device Outcomes: Surveillance of High-Voltage Leads.

Parkash R, Thibault B, Philippon F, Yee R, Stephenson E, Healey J, Krahn A, Exner D, Simpson C, Crystal E, Nery P, Essebag V, Sterns L, Tang A, Wells G.

Can J Cardiol. 2018 Jun;34(6):808-811. doi: 10.1016/j.cjca.2018.02.009. Epub 2018 Feb 19.

PMID:
29801745
6.

Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy: The VANISH Trial.

Coyle K, Coyle D, Nault I, Parkash R, Healey JS, Gray CJ, Gardner MJ, Sterns LD, Essebag V, Hruczkowski T, Blier L, Wells GA, Tang ASL, Stevenson WG, Sapp JL.

JACC Clin Electrophysiol. 2018 May;4(5):660-668. doi: 10.1016/j.jacep.2018.01.007. Epub 2018 Mar 28.

PMID:
29798795
7.

Differentiating Ventricular From Supraventricular Arrhythmias Using the Postpacing Interval After Failed Antitachycardia Pacing.

Bennett MT, Leader N, Sapp J, Parkash R, Gardner M, Healey JS, Thibault B, Sterns L, Essebag V, Birnie D, Sivakumaran S, Nery P, Andrade JG, Krahn AD, Tang A.

Circ Arrhythm Electrophysiol. 2018 Apr;11(4):e005921. doi: 10.1161/CIRCEP.117.005921.

PMID:
29618476
8.

Mexiletine or catheter ablation after amiodarone failure in the VANISH trial.

Deyell MW, Steinberg C, Doucette S, Parkash R, Nault I, Gray C, Essebag V, Gardner M, Sterns LD, Healey JS, Hruczkowski T, Rivard L, Leong-Sit P, Nery PB, Sapp JL.

J Cardiovasc Electrophysiol. 2018 Apr;29(4):603-608. doi: 10.1111/jce.13431. Epub 2018 Feb 1.

PMID:
29356207
9.

Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease).

Parkash R, Nault I, Rivard L, Gula L, Essebag V, Nery P, Tung S, Raymond JM, Sterns L, Doucette S, Wells G, Tang ASL, Stevenson WG, Sapp JL.

Circ Arrhythm Electrophysiol. 2018 Jan;11(1):e005663. doi: 10.1161/CIRCEP.117.005663.

PMID:
29305400
10.

Defibrillator shocks and their effect on objective and subjective patient outcomes: Results of the PainFree SST clinical trial.

Sears SF, Rosman L, Sasaki S, Kondo Y, Sterns LD, Schloss EJ, Kurita T, Meijer A, Raijmakers J, Gerritse B, Auricchio A.

Heart Rhythm. 2018 May;15(5):734-740. doi: 10.1016/j.hrthm.2017.12.026. Epub 2017 Dec 24.

11.

Canadian Registry of Implantable Electronic Device Outcomes: Longer-term follow-up of the Riata lead under advisory.

Parkash R, Thibault B, Philippon F, Mangat I, Coutu B, Bennett M, Crystal E, Healey J, Verma A, Sandhu R, Cameron D, Ayala-Paredes F, Sterns L, Essebag V, Sturmer M, Nery P, Wells G, Krahn A.

Heart Rhythm. 2018 Apr;15(4):524-529. doi: 10.1016/j.hrthm.2017.11.033. Epub 2017 Dec 2.

PMID:
29198903
12.

Management of Implantable Cardioverter Defibrillator Recipients: Care Beyond Guidelines.

Philippon F, Sterns LD, Nery PB, Parkash R, Birnie D, Rinne C, Mondesert B, Exner D, Bennett M.

Can J Cardiol. 2017 Aug;33(8):977-990. doi: 10.1016/j.cjca.2017.05.012. Epub 2017 May 26. Review.

PMID:
28754398
13.

Inappropriate shocks in single-chamber and subcutaneous implantable cardioverter-defibrillators: a systematic review and meta-analysis.

Auricchio A, Hudnall JH, Schloss EJ, Sterns LD, Kurita T, Meijer A, Fagan DH, Rogers T.

Europace. 2017 Dec 1;19(12):1973-1980. doi: 10.1093/europace/euw415. Review.

14.

Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.

Sapp JL, Parkash R, Wells GA, Yetisir E, Gardner MJ, Healey JS, Thibault B, Sterns LD, Birnie D, Nery PB, Sivakumaran S, Essebag V, Dorian P, Tang AS.

Circ Arrhythm Electrophysiol. 2017 Mar;10(3). pii: e004875. doi: 10.1161/CIRCEP.116.004875.

PMID:
28292754
15.

Canadian Cardiovascular Society/Canadian Heart Rhythm Society 2016 Implantable Cardioverter-Defibrillator Guidelines.

Bennett M, Parkash R, Nery P, Sénéchal M, Mondesert B, Birnie D, Sterns LD, Rinne C, Exner D, Philippon F, Campbell D, Cox J, Dorian P, Essebag V, Krahn A, Manlucu J, Molin F, Slawnych M, Talajic M.

Can J Cardiol. 2017 Feb;33(2):174-188. doi: 10.1016/j.cjca.2016.09.009. Epub 2016 Oct 6.

PMID:
28034580
16.

Atrioventricular Nodal Non Re-Entrant Tachycardia (AVNNT).

Sugumar H, Tung M, Leather R, Lane C, Sterns LD, Novak PG.

Heart Lung Circ. 2017 May;26(5):524-525. doi: 10.1016/j.hlc.2016.07.014. Epub 2016 Aug 30. Review. No abstract available.

PMID:
27769757
17.

Canadian Registry of Implantable Electronic Device Outcomes: Surveillance of the Riata Lead Under Advisory.

Parkash R, Thibault B, Mangat I, Coutu B, Bennett M, Healey J, Verma A, Philippon F, Sandhu R, Cameron D, Ayala-Paredes F, Sterns L, Essebag V, Kus T, Nery P, Stephenson E, Yee R, Exner D, Toal S, Birnie D, Wells G, Krahn A.

Circ Arrhythm Electrophysiol. 2016 Oct;9(10). pii: e004282.

PMID:
27733493
18.

Ejectable loop recorders?

Sugumar H, Tung MK, Lane C, Sterns LD, Novak PG, Leather R.

Heart Rhythm. 2016 Oct;13(10):2105. doi: 10.1016/j.hrthm.2016.05.027. Epub 2016 May 31. No abstract available.

PMID:
27261071
19.

Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.

Sapp JL, Wells GA, Parkash R, Stevenson WG, Blier L, Sarrazin JF, Thibault B, Rivard L, Gula L, Leong-Sit P, Essebag V, Nery PB, Tung SK, Raymond JM, Sterns LD, Veenhuyzen GD, Healey JS, Redfearn D, Roux JF, Tang AS.

N Engl J Med. 2016 Jul 14;375(2):111-21. doi: 10.1056/NEJMoa1513614. Epub 2016 May 5.

20.

Clinically Significant Pocket Hematoma Increases Long-Term Risk of Device Infection: BRUISE CONTROL INFECTION Study.

Essebag V, Verma A, Healey JS, Krahn AD, Kalfon E, Coutu B, Ayala-Paredes F, Tang AS, Sapp J, Sturmer M, Keren A, Wells GA, Birnie DH; BRUISE CONTROL Investigators.

J Am Coll Cardiol. 2016 Mar 22;67(11):1300-8. doi: 10.1016/j.jacc.2016.01.009.

Supplemental Content

Loading ...
Support Center